Source Fact: Financial Supervisory Service DART / 2025-09-10
Disclosure Type: Report on Investor Relations (IR) Holding
💡 3-Second Summary
Alteogen will participate in a presentation session at the ‘Hankyung Korea Investment Week 2025’ held at Conrad Seoul on September 17 to explain its bio platform technology and pipeline status/plans to domestic and overseas investors and the press.
📊 1. [Key Disclosure Content & Major Figures Summary]
- Date & Time: September 17, 2025 (13:50 – 14:20 Local Time)
- Location: Grand Ballroom, Conrad Seoul, Yeouido
- Target Audience: Domestic and overseas investors, the press, etc.
- Purpose: Introduction of the company’s core technology and vision
- Method: Participation in the presentation session of Hankyung Korea Investment Week 2025
- Key Topics: Alteogen’s bio platform technology and pipeline status/plans
- Sponsoring Institution: The Korea Economic Daily
- IR Material Availability: Scheduled to be posted on the Korea Exchange’s KIND website on September 17, 2025
📈 2. [Expert View: What This Disclosure Means for Investors]
This disclosure is an announcement regarding Alteogen participating in a presentation session for domestic and overseas investors and the press. According to the disclosure, the event will be held via participation in a presentation session at the Hankyung Korea Investment Week 2025, covering explanations regarding its bio platform technology and pipeline status/plans.
The purpose is specified as introducing the core technology and vision, and the disclosure does not explain any specific financial impacts or potential changes in financial metrics. Investors may review the related facts through the IR materials scheduled to be available on the Korea Exchange website on September 17. Since any prospective impacts or market outcomes beyond the official text remain uncertain, investors should interpret this disclosure focusing strictly on the confirmed event details and schedules.
📝 Editor’s Comment (by K-STOCK Editor)
This Investor Relations event announced by Alteogen is a presentation schedule taking place at Conrad Seoul on September 17, 2025, for domestic and overseas investors and the press. The official purpose stated in the disclosure is introducing the bio platform technology and pipelines, with The Korea Economic Daily as the sponsoring institution. The official IR materials are scheduled to be posted on the Korea Exchange network on September 17, and tracking should be limited strictly to these verified facts and schedules.
📢 Disclaimer & Source Information
Source: This content has been newly structured and written based on the official data submitted to the Financial Supervisory Service Electronic Disclosure System (DART).
Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest solely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
🔥 Bulls vs Bears, drop your analysis in the comments!